Results 41 to 50 of about 72,227,010 (294)

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Ancylis sederana Chrétien, 1915 a new species to the European fauna from Spain (Lepidoptera: Tortricidae)

open access: yesSHILAP, 2019
Ancylis sederana Chrétien, 1915 is for the first time reported from Europe. During an expedition in Southern Spain, the first author captured a female of this species near Almeria.
F. Graf, T. Sobczyk
doaj   +1 more source

Historico-philosophical Research in Independent Ukraine (expert poll)

open access: yesSententiae, 2021
An expert poll of Sententiae.
Serhii Yosypenko   +4 more
doaj   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

First female record of the Psychidae species Dahlica michaela Arnscheid, 2016, in the Pyrenees of Huesca in Aragon (Spain) (Lepidoptera: Psychidae, Naryciinae)

open access: yesSHILAP, 2018
In 2016 the senior author described the Psychidae species Dahlica michaela from the Pyrenees of Aragon based on 10 males, reared from larvae. No females were included in the type series.
W. A. Arnscheid, M. R. Gärtner
doaj   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Keen Independent Research -- Oregon MHRA diversity study 2022

open access: yes, 2022
Oregon Mental Health Regulatory Agency (MHRA) seeks to support the diversity of professionals licensed by the Oregon Boards of Psychology (OBOP) and Licensed Professional Counselors and Therapists (OBLPCT).

core  

Price-forming factors choice grounding at intangible assets with negative depreciation independent valuation/appraising [PDF]

open access: yes, 2020
Independent expert valuation/appraising of intellectual property rights objects, such as brands and goodwill, performed by the Costs approach, is based on economic indicators of these intangible assets utility degree, which are connected with the sum of ...
Zoryana, Skybinska   +2 more
core  

New data on Pyraloidea from the Canary Islands, Spain 2 (Lepidoptera: Pyralidae, Crambidae

open access: yesSHILAP, 2022
We describe six new species of Pyraloidea from the Canary Islands, Spain: Dioryctria mieella Falck, Karsholt & Slamka, sp. n., Euzophera mirumella Falck, Karsholt & Slamka, sp. n., Dalakia moyalis Falck, Karsholt & Slamka, sp.
P. Falck, O. Karsholt, F. Slamka
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy